NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT03738163,A Clinical Investigation With EpadermÂ® Cream,https://clinicaltrials.gov/study/NCT03738163,PD-539878,COMPLETED,"This investigation is designed as a prospective, non-randomised, single arm clinical investigation. Data is collected from approximately 120 evaluable subjects, divided into three groups of approximately 40 subjects; infants (0-36 months old), children (3-18 years old) and adults (\>18 years old), with the following indications: eczema, psoriasis and other dry skin conditions. Each subject will be followed during 4 weeks treatment, with a visit at baseline (visit 1), at 2 weeks (visit 2) and at 4 weeks (visit 3) treatment.",YES,Eczema|Psoriasis|Dry Skin; Eczema,DEVICE: Epaderm Cream,"Number of Participants With Improved Skin Moisturization, Participants were considered to have improved moisturization if they responded strongly agree or agree on the questionnaire. Evaluations were carried out in the same affected spot from a scale of Strongly agree, Agree, Neither agree nor disagree,

Disagree, Strongly disagree where Strongly agree is the most improved skin moisturization:, Assessed at 2 weeks and 4 weeks visit, 4 weeks visit reported","Number of Participants With Improved Skin Softness, Participants were considered to have improved softness if they responded strongly agree or agree on the questionnaire. Evaluations were carried out in the same affected spot from a scale of Strongly agree, Agree, Neither agree nor disagree, Disagree, Strongly disagree where Strongly agree is the most improved skin softness., Assessed at 2 weeks and 4 weeks visit, 4 weeks visit reported|Number of Participants With Improved Overall Dry Skin/Xerosis, Participants were considered to have improved overall dry skin if they responded 'absent' or 'faint scaling' on the questionnaire. Evaluations were carried out in the same affected spot from a scale of 0= Absent, 1= Faint scaling, faint roughness and dull appearance, 2= Small scales in combination with a few larger scales, slight roughness, whitish appearance, 3= Small and larger scales uniformly distributed, definite roughness, possibly slight redness and possibly a few superficial cracks, 4= Dominated by large scales, advanced roughness, redness present, eczematous changes and cracks where 'absent' or 'fanit scaling' refers to improved overall dry skin., Assessed at 2 weeks and 4 weeks visit, 4 weeks visit reported|Number of Participants Who Confirmed Overall Effect and Comfort of Treatment, Participants confirmed the comfort during treatment from a scale of Very Poor, Poor, Average, Good and Excellent where Excellent is considered the most comforting during treatment., Assessed at 2 weeks and 4 weeks visit, 4 weeks visit reported|Number of Participants With Adverse Device Effects (ADEs), Number of Adverse Device Effects (ADEs) related to the use of Epaderm Cream during the investigation., Evaluated at every follow-up visit (2 weeks and 4 weeks visit)|Number of Participants Who Reported Applying Epaderm Cream Twice a Day, Frequency of Epaderm Cream application. Participants were asked how often Epaderm Cream was applied either once a day, twice a day, three times a day or four times a day with twice a day application being the most frequent., Assessed at 2 weeks and 4 weeks visit, 4 weeks visit reported|Number of Participants With Improvement of Skin Moisturization By Week 4, Participants confirmed the time to visualize improvement of skin moisturization from the range immediately, within 2 weeks or not at all where immediately refers to the most increased improvements seen., Assessed at 2 weeks and 4 weeks visit. Improvement within 4 weeks visit reported.|Number of Participants Who Used Epaderm as a Skin Cleanser, Participants were asked to confirm if the product was used as a skin cleanser by answering yes or no where yes confirmed use of Epaderm cream as a skin cleanser., Assessed at 2 weeks and 4 weeks visit, 4 weeks visit reported where participates answered 'yes'.",,Molnlycke Health Care AB,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,121,INDUSTRY,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,Epaderm01,2019-04-01,2019-10-25,2020-06-17,2018-11-13,2020-09-09,2021-06-23,"Poole Hospital NHS Foundation Trust, Poole, Dorset, BH15 2JB, United Kingdom|Whiteladies Medical Group, Bristol, BS8 2 PU, United Kingdom","Study Protocol and Statistical Analysis Plan, https://storage.googleapis.com/ctgov2-large-docs/63/NCT03738163/Prot_SAP_000.pdf"
